Artivion (AORT) Total Non-Current Liabilities (2010 - 2026)
Artivion's (AORT) quarterly Total Non-Current Liabilities came in at $423.5 million in Q1 2026, down 5.22% YoY from $446.9 million in Q1 2025, and down 0.92% on a QoQ basis from $427.5 million in Q4 2025.
Artivion (AORT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Artivion (AORT) has 17 years of Total Non-Current Liabilities data on file, last reported at $423.5 million in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 5.22% year-over-year to $423.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $423.5 million (down 5.22% YoY) and the FY2025 annual result came in at $427.5 million, down 15.33% from the prior year.
- Total Non-Current Liabilities fell to $423.5 million in Q1 2026, from $427.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $504.8 million in Q4 2024 to a low of $409.5 million in Q2 2025.
- A 5-year average of $449.4 million and a median of $442.6 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities advanced 13.01% — and 2025, when it declined 16.38%.
- Tracing AORT's Total Non-Current Liabilities over 5 years: stood at $438.1 million in 2022, then rose by 1.98% to $446.7 million in 2023, then increased by 13.01% to $504.8 million in 2024, then fell by 15.33% to $427.5 million in 2025, then dropped by 0.92% to $423.5 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $423.5 million (Q1 2026), $427.5 million (Q4 2025), and $409.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.74 Bn | 197.14 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.22 Bn | 123.75 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.44 Bn | 110.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.78 Bn | 74.24 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.81 Bn | 47.56 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.98 Bn | 33.03 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.79 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.24 Bn | 22.76 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Artivion | 1.38 Bn | 1.30 Bn | 80.52 Mn | 554.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 554.83 Mn |
| Mar 31, 2026 | 423.53 Mn |
| Dec 31, 2025 | 427.46 Mn |
| Sep 30, 2025 | 409.69 Mn |
| Jun 30, 2025 | 409.53 Mn |
| Mar 31, 2025 | 446.86 Mn |
| Dec 31, 2024 | 504.84 Mn |
| Sep 30, 2024 | 489.93 Mn |
| Jun 30, 2024 | 446.28 Mn |
| Mar 31, 2024 | 442.62 Mn |
| Dec 31, 2023 | 446.73 Mn |
| Sep 30, 2023 | 440.51 Mn |
| Jun 30, 2023 | 487.88 Mn |
| Mar 31, 2023 | 431.96 Mn |
| Dec 31, 2022 | 438.07 Mn |
| Sep 30, 2022 | 480.97 Mn |
| Jun 30, 2022 | 476.66 Mn |
| Mar 31, 2022 | 436.76 Mn |
| Dec 31, 2021 | 485.84 Mn |
| Sep 30, 2021 | 494.87 Mn |